Delivery Order SPE2DB20D3101-SPE2DB21FK3J8

Award Date 8/24/21
Potential Completion Date 8/25/21
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,176.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,564,502,725 units of Bupropion HCL XL 300 mg tablets, a medication used to treat depression. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $29,534.76 firm-fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets, a generic medication used to treat depression. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,688.03, is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $5,768.03 for the supply of 500 units of BUPROPION HCL XL 300 MG TABLET to the agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is not designated as a set-aside contract and was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,236.40 firm fixed-price delivery order is for 4554453792 Bupropion HCL XL 150 mg tablets, with an ultimate completion date of August 18, 2021. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,854.28, is for the delivery of Bupropion HCL XL 300 mg tablets over the period ending on January 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, a medication used to treat depression and other mental health conditions, to support military treatment facilities and veterans' healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $33,837.57,...
This federal contract award, valued at $58,566.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,286,845 units of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and certain other conditions. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $7,918.42 firm fixed-price delivery order is for the supply of 500 count bottles of 150 mg Bupropion HCL XL tablets, with a performance period through March 2024. The award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $18,004.58, with a completion date of February 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK3J8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,069.10 firm fixed-price delivery order covers the supply of 4554558833 tablets of Bupropion HCL XL 300 mg, a generic medication used to treat depression and smoking cessation.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

In addition to the DLA IDC, Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse pharmaceutical needs of multiple government agencies.

Generated 2/27/25, 11:35 AM